Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2024-07-02 00:00:00 ET · period of report 2024-06-30 · accession 0001801170-24-000145 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-02 | 2024-06-30 | CLOV | Reynoso Jamie L. | CEO, Medicare Advantage | A - Grant | $0.00 | +217.5K | 2.68M | +9% | $0 | |
| 2024-07-02 | 2024-06-30 | CLOV | Reynoso Jamie L. | CEO, Medicare Advantage | F - Tax | $1.23 | -53.0K | 2.62M | -2% | -$65.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-06-30 | A | A | 217,522 | $0.00 | 2,676,975 | D | — | — | (F1) Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned restricted stock units vested and were settled on June 30, 2024, and the remaining one-third of the restricted stock units will vest on June 30, 2025, subject to the Reporting Person's continued employment on such vesting date. |
| 2 | Common | Class A Common Stock | 2024-06-30 | F | D | 52,967 | $1.23 | 2,624,008 | D | — | — | (F2) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of 1/3 of the number of earned restricted stock units, as described above. |